PB1846: ALTERATIONS IN PRIMARY HEMOSTASIS AS ADDITIONAL RISK FACTORS OF BLEEDING IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML): UPDATED PROSPECTIVE ANALYSIS. by Z. Stupakova, D. Iryna, M. Zoya, S. Anna, O. Karnabeda, U. Melnyk, O. Novosad

Get full text

PB2283: COVID-19 (SARS-COV-2 INFECTION) IN LYMPHOMA PATIENTS by I. Tytorenko, I. Kryachоk, O. Alexik, T. Kadnikova, A. Martynchik, O. Novosad, Y. Pastyshenko, Y. Stepanishina, N. Shokun, K. Filonenko

Get full text

PB2114: TREATMENT RESULTS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA FROM HIGH-RISK GROUP by K. Filonenko, I. Kriachok, A. Martynchyk, I. Titorenko, Y. Stepanishyna, O. Aleksyk, K. Ukianchenko, I. Pastushenko, Y. Kushchevyy, O. Novosad, O. Karnabeda, I. Diagil, V. Kozlov

Get full text

PB2065: IMPORTANCE OF PET AS A PROGNOSTIC MARKER IN TREATMENT STRATEGY CHOICE IN PATIENTS WITH HODGKIN LYMPHOMA by O. Novosad, I. Pastushenko, T. Kadnikova, I. Tytorenko, A. Martynchyk, O. Gorbach, A. Ashyhmin, Y. Kmetyuk, O. Karpova, L. Mykhalska, O. Kindrakevych, M. Novikov, O. Oliinichenko, I. Kriachok

Get full text